Page 33 - MALAYSIAN PATIENT SAFETY GOALS
P. 33

TECHNICAL SPECIFICATIONS OF MALAYSIAN PATIENT SAFETY GOALS & KPIs
                                                               rd
        Patient Safety      To implement the WHO’s 3 Global Patient Safety Challenges-
        Goal  No. 4         “Tackling Antimicrobial Resistance”
        Rationale           Antimicrobial resistance poses a growing threat to the treatment
                            and control of infections.
        Strategies &        1. The Malaysian National Antibiotic Guidelines are implemented.
        Implementation 2. National and State Campaign on Containment of Antimicrobial
                               Resistance
                            3. Antibiotic Stewardship Programme

        KPI No. 5           Incidence Rate Of MRSA Infection

        Numerator (N)       Number of patients with MRSA infection in the hospital
        Denominator (D)     Total number of hospital admissions
        Formula              (N/D) x 100
        Target              ≤0.4%
        KPI No. 6           Incidence Rate Of ESBL- Klebsiella pneumonia Infection
        Numerator (N)       Number of patients with ESBL- Klebsiella pneumoniae infection in the
                            hospital
        Denominator (D)     Total number of hospital admissions
        Formula             (N/D) x 100
        Target              ≤0.3%
        KPI No. 7           Incidence Rate Of ESBL- E.coli Infection
        Numerator (N)       Number of patients with ESBL- E.coli infection in the hospital
        Denominator (D)     Total number of hospital admissions
        Formula             (N/D) x 100
        Target              ≤0.2%
        Definition of       Case definitions:
        Terms               MDRO (Multi-Drug Resistant Organisms) case definition must fulfill ALL of
                            the following criteria:
                            1)Isolation of an MDRO from any body sites
                            2)The patient must be admitted to the ward
                            3)The case must be “Newly Identified”
                            “Newly Identified” include:
                            I.MDRO identified for the first time during current hospital admission
                            II.Cases that have been identified at your site but acquired “new infection”
                            (infection with organism having different antibiogram or defined as new
                            infection by the attending clinician)
                            Population under surveillance is all in-patients - Exclusion:
                            1)Cases from Emergency department, clinic or other outpatient services
                            2)Cases previously identified at other acute care facilities/hospitals
                            3)Cases re-admitted with same alert organisms within one year
                            4)Cases with insufficient information on healthcare exposure
                            5)Cases from screening culture
                            6)Coloniser


        Data collection at Monthly
        facility level
        Reference           Alert Organism Surveillance Manual, Ministry Of Health 2012



                                                           32
   28   29   30   31   32   33   34   35   36   37   38